Phio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | -2 | -1,074 | |
EBITDA | -2,533 | -2,390 | -2,308 | -1,769 |
EBIT | -2,534 | -2,392 | -2,309 | |
Net Income | -2,371 | -2,392 | -2,166 | -1,769 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,079 | -2,092 | -2,543 | -1,277 |
Cash | 21,031 | 10,705 | 10,775 | 13,278 |
Basic Shares | 11,617 | 5,468 | 4,794 | 4,307 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3 | -3,643 | -6,332 | -193 |
EBITDA | -9,217 | -7,385 | -10,642 | -11,269 |
EBIT | -9,220 | -7,387 | -10,826 | -11,462 |
Net Income | -8,698 | -7,150 | -10,826 | -11,305 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,991 | -7,113 | -10,754 | -12,250 |
Cash | 21,031 | 5,382 | 8,490 | 11,781 |
Basic Shares | 5,984 | 787 | 231 | 126 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.20 |
2025-09-30 | -$0.44 |
2025-06-30 | -$0.45 |
2025-03-31 | -$0.93 |
